Follow-up in Active Surveillance for Prostate Cancer: Strict Protocol Adherence Remains Important for PRIAS-ineligible Patients

Authors:

Abstract
No abstract available
Funding Information
  • Astellas Pharma and Amgen

This publication has 23 references indexed in Scilit: